HomeOCX • NASDAQ
add
OncoCyte Corp
Previous close
$3.05
Day range
$2.91 - $3.08
Year range
$2.08 - $5.40
Market cap
39.16M USD
Avg Volume
118.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 314.00K | 14.60% |
Operating expense | 4.96M | -17.32% |
Net income | -15.99M | 64.44% |
Net profit margin | -5.09K | 68.97% |
Earnings per share | — | — |
EBITDA | -4.73M | -0.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.43M | -53.82% |
Total assets | 74.89M | -25.18% |
Total liabilities | 49.30M | -18.51% |
Total equity | 25.59M | — |
Shares outstanding | 8.27M | — |
Price to book | 1.23 | — |
Return on assets | -16.16% | — |
Return on capital | -34.17% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -15.99M | 64.44% |
Cash from operations | -4.56M | 52.72% |
Cash from investing | 241.00K | 130.05% |
Cash from financing | -30.00K | 70.00% |
Net change in cash | -4.35M | 58.76% |
Free cash flow | 1.63M | 124.97% |
About
Founded
2009
Headquarters
Website
Employees
45